Materna Medical, a Fogarty Innovation company focused on transforming women’s pelvic health, recently raised an impressive $20 million in Series B funding led by investment firm InnovaHealth Partners. This comes on the heels of a $10 million Series A2 funding in 2021,...
Search Results
Greta Meyer, Ferolyn Fellow
A former world-class lacrosse player, Greta Meyer is no stranger to hard work, teamwork and perseverance, just a few of the key traits that make for a great entrepreneur and Ferolyn Fellow. Sports also led to her innovation, as she experienced first-hand the...
A Conversation with Rob Binney, CEO of Alydia Health
Alydia Health was one of the first Companies-in-Residence at Fogarty Innovation and one the organization has been deeply passionate about, with its promise to solve postpartum hemorrhage (PPH). An enormous unmet need, PPH is the leading cause of maternal...
Women’s Healthcare Leader Materna Medical Raises $10M in Series A2 Financing Round
Women’s healthcare continues to attract much-deserved investor attention. Subsequent to Fogarty graduate Alydia Health’s acquisition by Merck’s spinoff Organon, another Fogarty company, Materna Medical, announced it has raised $10 million in a Series A2 financing...
Interview with Amanda French, Co-Founder and CEO of Emme
If you forget to take a vitamin here and there, you’ll probably be fine. But forget to take a birth control pill, and you could well end up with a very unexpected situation. That’s where the Emme Smart Birth Control System performs an invaluable service as it...
Raydiant Oximetry Receives $3 Million Grant to Advance Its Innovative Technology
As C-sections continue to rise worldwide, more mothers and babies are at risk from perinatal complications. Raydiant Oximetry, a Fogarty Innovation graduate, is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth and...
Spotlight: Holly Rockweiler, Ferolyn Fellow
In a year like no other, we all searched for silver linings. One of them was the ongoing success of numerous programs at Fogarty Innovation, including the Ferolyn Fellowship, which continued to foster relationships with inspiring medtech innovators like Holly...
Madorra’s Device Sparks Overwhelming Interest
“We were given a gift to be able to solve a big problem, and though the road to getting a device to market is often a bumpy one, we have never lost our resolve to keep moving forward.” That focus from Madorra, a Fogarty Institute graduate aiming to improve the quality...
Q&A With Holly Rockweiler, CEO and Co-Founder of Madorra
A former Stanford Biodesign Fellow and Fogarty Institute entrepreneur, 32-year-old Holly Rockweiler has already had remarkable accomplishments early in her career, fluently moving her startup to the next level. Most notably, Holly has parlayed Madorra’s impressive...
Raydiant Oximetry shows promise to vastly improve fetal health monitoring
When Neil Ray, MD, a pediatric anesthesiologist by training, was working in private practice in South Florida, he was surprised to learn that nearly half of women gave birth via a caesarean section, and often, these surgeries weren't necessary as both the baby and...